Search

everythinglearnresearchcommunity

for

Search:↓

Infant hair loss is usually temporary and grows back without treatment.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

Stress, hypothyroidism, drug intake, and anemia are important factors in women's diffuse hair loss.

The study found that it's hard to tell the difference between two types of hair loss, alopecia areata and telogen effluvium, by looking at symptoms and tissue samples.

COVID-19 can cause temporary hair loss in some people.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Amitriptyline can cause temporary hair loss, which stops after discontinuing the drug.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

5% topical minoxidil may help reduce hair loss and increase hair growth in telogen effluvium.

People with chronic hair loss often have lower Vitamin B12 levels.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Many patients with hair loss had low iron and vitamin D levels, but thyroid issues were not common.

Biotin deficiency is not a major cause of Telogen Effluvium hair loss.

Serum ferritin can help diagnose Telogen Effluvium.

People with Chronic Telogen Effluvium mainly have lower iron levels compared to healthy individuals.

Platelet-rich plasma is a promising and safe treatment for increasing hair density and thickness in women with chronic telogen effluvium.

Both trichoscopy and folliscopy accurately diagnose telogen effluvium, but trichoscopy is easier and faster.

Both parties agree that cell death is important in the hair cycle, but they have different views on the role of the catagen phase and hair shedding.

Etretinate treatment changed hair growth patterns in many patients.

COVID-19 can cause hair loss due to stress, with inflammation markers like D-dimer levels playing a role.

COVID-19 increased hair loss cases, but vaccination did not.

The 675-nm diode laser may safely help treat telogen effluvium.

Most women in the study lost hair due to stress, fever, childbirth, surgery, or thyroid issues, with low hemoglobin levels also common.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Poor nutrition is linked to increased hair loss in Canadian children.

One supplement improved hair loss and quality faster and more effectively than the other in treating telogen effluvium.

Low ferritin and vitamin D levels are linked to hair loss.

Scalp treatments increased hair density and reduced hair loss in Telogen Effluvium patients.